Although the use of tyrosine kinase inhibitors (TKIs), such as sunitinib, has led to impressive advancements in the treatment of clear cell renal cell carcinoma (ccRCC), primary or acquired resistance ...
Structure of the TRAIL–DR5 complex reveals mechanisms conferring specificity in apoptotic initiation
EST database searching has led to the cloning and characterization of a number of proteins belonging to the tumor necrosis factor (TNF) and TNF receptor (TNF–R) families. Although structurally related ...
A phase I study of CS-1008 (humanized monoclonal antibody targeting death receptor 5 or DR5), administered weekly to patients with advanced solid tumors or lymphomas This is an ASCO Meeting Abstract ...
68Ga-HER2 affibody PET/CT imaging as an option in patients whose HER2 status of any tumor in the body needs to be deciphered. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This ...
A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University ...
News Letter on MSN
'Project continues to make excellent progress': Northern Ireland biotech firm secures grant extension for cancer treatment development project
Fusion Antibodies says the programme showcases Northern Ireland’s growing capabilities in advanced medicines and antibody development ...
Home » DR5 as promising CAR T-cell target allowing inhibition of tumor cells and MDSCs To read the full story, subscribe or sign in. Immuno-oncology ...
A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results